Article

Revolutionizing neurodegenerative disease research with brain-on-chip technology

Physiological512x288

Organ-on-chips have emerged as a promising tool for advancing neurological drug development. Excited by the potential, preclinical Contract Research Organization ETAP-Lab is combining its neurotoxin manufacturing capabilities with NETRI’s NeuroFluidics technology. In a conversation with ETAP-Lab’s CEO, Nicolas Violle, we delved into the details of their advanced cell models and the potential transformative impact on the field of neuroscience.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Revolutionizing neurodegenerative disease research with brain-on-chip technology

Download Article